Menu open

STUDY FOCUS AREAS

Our implementation research projects have a global reach and focus on improving the HIV prevention and care continuum.

We are dedicated to identifying strategies to bridge the gap between the availability of effective HIV medications and the access and use of those medicines to better the lives of people living with HIV and of individuals seeking HIV prevention options.

  • Implementation of Novel HIV Prevention and Treatment

    Developing and effectively implementing long-acting HIV prevention and treatment medications is crucial for optimal access and uptake. Our studies focus on identifying the best strategies to support the successful implementation of these medicines for people living with HIV and people who could benefit from PrEP.

  • Supporting People Through All Stages of Life

    We are committed to supporting people living with HIV and people who could benefit from PrEP throughout their lives. Our implementation science research projects focus on overcoming several barriers, including missed opportunities to test pregnant women for HIV and testing children at birth, poor linkage to care, low retention in care, and viral load suppression challenges. We are committed to better measurement of health-quality of life, improving the mental health and well-being of people living with and ageing with HIV, leveraging technology to deliver high quality HIV care, and ensuring the voices of people living with HIV are heard.

  • Adherence and Retention Across the HIV Care Continuum

    We are dedicated to enhancing the HIV care continuum by preventing loss to follow-up, promoting adherence, and improving access to services and medications. Our research focuses on PrEP access and uptake, diagnosing new patients, ensuring appointment attendance, encouraging adherence to HIV medicines, and overcoming barriers to care for people living with HIV and those who could benefit from PrEP.

  • Stigma & Discrimination

    Despite considerable efforts, HIV-related stigma and discrimination persist. Our implementation research projects focus on spreading the U=U message and HIV awareness. We are committed to eliminating stigma and discrimination, which deter health-seeking behaviors, including HIV prevention, and impact the quality of life for people living with HIV or people who could benefit from PrEP

NP-GBL-HVU-WCNT-250003 | January 2025

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.